PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
Laura L. Stafman(University of Alabama at Birmingham), Elizabeth A. Beierle(University of Alabama at Birmingham)
Cited by 15
Related Papers
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
|Oncotarget|2018|30
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
|PLoS ONE|2013|29
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
|Scientific Reports|2018|24
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
|Scientific Reports|2021|12
Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype
|Journal of Pediatric Surgery|2023|3